Results 21 to 30 of about 59,669 (311)
Endocrinology, Diabetes &Metabolism, Volume 6, Issue 1, January 2023., 2023 This study describes the clinical and laboratory profile and outcomes of hospitalized COVID‐19 patients with type 2 diabetes mellitus (DM) in Ghana. Out of 175 patients (mean age 55.9+/−18.3 years) 64 (36.6%) had DM. Compared to non‐diabetics, DM patients were older (61.1? 12.8 vs. 53.0?
Yasmine Oladele Hardy +13 more
wiley +1 more source
European Journal of Immunology, Volume 53, Issue 1, January 2023., 2023 B lineage cells have been identified as therapeutic targets in autoimmune diseases. In the current review article, we provide an overview of novel strategies to target B lineage cells in autoimmune diseases, with a focus on inflammatory rheumatic diseases.
Ana Merino‐Vico +3 more
wiley +1 more source
PLoS ONE, 2022 Preeclampsia is a multi-system disease that can have severe, even fatal implications for the mother and fetus. Abnormal placentation can lead to ischaemic tissue injury and placental inflammation.
Elif Kadife +5 more
doaj +2 more sources
Hydroxychloroquine: Not a Heart Breaker! [PDF]
Arthritis Care & Research, 2021 Prior to 2020, there was a lack of general awareness of hydroxychloroquine's (HCQ) and chloroquine's (CQ) potential for cardiac arrhythmias, as rheumatologists and dermatologists have prescribed these medications for decades with no obvious cardiac safety signal.
Desmarais, Julianna, Link, Mark S.
openaire +3 more sources
Characterizing Vaccination Movements on YouTube in the United States and Brazil [PDF]
Proceedings of the 33rd ACM Conference on Hypertext and Social
Media. 2022. p. 80-90, 2022 In the context of COVID-19 pandemic, social networks such as Twitter and YouTube stand out as important sources of information. YouTube, as the largest and most engaging online media consumption platform, has a large influence in the spread of information and misinformation, which makes it important to study how it deals with the problems that arise ...
arxiv +1 more source
PLoS ONE, 2021 ObjectivesHydroxychloroquine is widely used to treat certain viral and rheumatic diseases including systemic lupus erythematosus. Cardiac arrhythmia is an important safety issue with hydroxychloroquine.
Chien-Hsien Lo +7 more
doaj +1 more source
On the Inhibition of COVID-19 Protease by Indian Herbal Plants: An In Silico Investigation [PDF]
Journal of the Indian Chemical Society, 2022, 2020 COVID-19 has quickly spread across the globe, becoming a pandemic. This disease has a variable impact in different countries depending on their cultural norms, mitigation efforts and health infrastructure. In India, a majority of people rely upon traditional Indian medicine to treat human maladies due to less-cost, easier availability and without any ...
arxiv +1 more source
Use of Hydroxychloroquine in Japan [PDF]
The Journal of Rheumatology, 2012 To the Editor: Antimalarial agents have been used for the treatment of inflammatory diseases for the last half century, with hydroxychloroquine (HCQ) being approved in the United States in 19551. In addition to its common use in systemic lupus erythematosus (SLE), including cutaneous forms, it has also proven useful in treating rheumatoid arthritis ...
Mitsumasa Kishimoto +4 more
openaire +3 more sources
Advanced Biomedical Research, 2016 Background: Hydroxychloroquine can improve most underlying coronary risk factors; however, there are a few studies on the effects of hydroxychloroquine on blood glucose and insulin resistance.
Fahimeh Sheikhbahaie +4 more
doaj +1 more source
Jornal Brasileiro de Pneumologia, 2021 Objective: Chloroquine or hydroxychloroquine has demonstrated no effect on the treatment of hospitalized COVID-19 patients. This study aimed to answer questions related to the use of hydroxychloroquine for pre-exposure or post-exposure prophylaxis of ...
Suzana E Tanni +3 more
doaj +2 more sources